2811 - 2820 of 6431 Results
Title
Year
-
OPENTitle: ECTRIMS 2021 – ePosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 27Issue #: 2_supplStart Page: 134End Page: 740Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585211044667Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13524585211044667Citation Count: 26
-
OPENTitle: ECTRIMS 2021 – Late Breaking News ePosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 27Issue #: 2_supplStart Page: 752End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585211047080Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13524585211047080Citation Count: 4
-
OPENTitle: ECTRIMS 2022 – PosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 3_supplStart Page: 130End Page: 691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585221123687Best OA location URL: https://lirias.kuleuven.be/bitstream/20.500.12942/704893/2/poster_ECTRIMS_RIMS_Oct%202022_Peeters.pdfCitation Count: 20
- Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype2021OPENTitle: Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker PhenotypeJournal Name: American Journal of Alzheimer's Disease & Other Dementias®Publisher: SAGE PublicationsVol: 36Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1177/1533317520981225Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1533317520981225Citation Count: 6
-
OPENTitle: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy ControlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdfCitation Count: 0
-
OPENTitle: A Severe Case of Lupus CerebritisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S9.full.pdfCitation Count: 1
-
OPENTitle: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 SequencesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S17.1.full.pdfCitation Count: 1
-
OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 3
-
OPENTitle: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 TherapiesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdfCitation Count: 1
-
OPENTitle: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdfCitation Count: 3